ARCHIVES

Velcade Improves Survival In Relapsed Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 28 No. 7 | July 29, 2005

Download PDF Visit The Full Archive

Related Articles

SWOG Releases RFA For Use Of Biorepository

November 12, 2010

NCAB Committee To Propose Event Marking Cancer Act

August 2, 1991

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

May 2, 2008

MSKCC In Outreach Agreement With Phelps

December 1, 1995

Facility Needs Panel Recommends $4.5-3 billion, Seven Year Program To Be Run By NIGMS Or DRR

March 4, 1988